MEXICO City (Reuters) – the Mexican pharmaceutical Genomma
Lab wants to buy American Prestige Brands Holdings
Inc by 16.60 dollars per share in cash, an operation
valued at 834 million dollars would give greater
presence in North America.
Genomma Lab said that the amount did not see net debt of
Prestige Brands, a company that markets and distributes
products for personal care and home in States
United, Canada and certain international markets.
“The price proposed (…)” “represents a premium of 23 by
cent with respect to the price of the shares of
Prestige at the close of the market on February 17, 2012 and
a premium of 47 percent from the average price of
historical quotation of the last three months”, said the company
in a statement.
Of Genomma Lab shares were suspended on Monday in
the stock exchange local in hopes that the company disclosure
information.
La Bolsa Mexicana de Valores said that you actions of the
pharmaceutical resume operations Tuesday.
